Vaccinex, Inc. (VCNX) Financials

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0.73
Day's range
$0.75
$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30M-$40M-$40MEarning201820182019201920202020202120212022202220232023202420240%0%-20000%-20000%-40000%-40000%-60000%-60000%-80000%-80000%-100000%-100000%Profit Margin
Profit Margin
Revenue
Earnings

VCNX Income statement / Annual

Last year (2024), Vaccinex, Inc.'s total revenue was $601.00 K, an increase of 5.44% from the previous year. In 2024, Vaccinex, Inc.'s net income was -$18.63 M. See Vaccinex, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $601.00 K $570.00 K $100.00 K $900.00 K $50.00 K $523.00 K $724.00 K $90.00 K $316.00 K
Cost of Revenue $0.00 $0.00 $207.00 K $169.00 K $2.00 K $199.00 K $1.03 M $160.00 K $115.00 K
Gross Profit $601.00 K $570.00 K -$107.00 K $731.00 K $48.00 K $324.00 K -$309.00 K -$70.00 K $201.00 K
Gross Profit Ratio 1 1 -1.07 0.81 0.96 0.62 -0.43 -0.78 0.64
Research and Development Expenses $12.55 M $16.57 M $13.98 M $17.16 M $21.55 M $25.67 M $22.35 M $16.55 M $16.03 M
General & Administrative Expenses $6.79 M $6.88 M $6.20 M $6.23 M $7.41 M $6.67 M $4.62 M $4.48 M $4.43 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $6.79 M $6.88 M $6.20 M $6.23 M $7.41 M $6.67 M $4.62 M $4.48 M $4.43 M
Other Expenses $0.00 $0.00 -$175.00 K $43.00 K -$575.00 K $152.00 K $165.00 K -$40.00 K -$4.00 K
Operating Expenses $19.34 M $23.46 M $20.01 M $23.39 M $28.38 M $32.34 M $26.97 M $21.03 M $20.46 M
Cost And Expenses $19.34 M $23.46 M $20.01 M $23.39 M $28.38 M $32.54 M $28.01 M $21.19 M $20.58 M
Interest Income $0.00 $0.00 $2.00 K $809.00 K $489.00 K $0.00 $0.00 $0.00 $0.00
Interest Expense $2.00 K $1.00 K $2.00 K $809.00 K $489.00 K $0.00 $392.00 K $1.36 M $2.99 M
Depreciation & Amortization $94.00 K $119.00 K $207.00 K $169.00 K $307.00 K $249.00 K $223.00 K $206.00 K $178.00 K
EBITDA -$18.54 M -$19.75 M -$19.61 M -$21.40 M -$28.06 M -$31.61 M -$28.90 M -$17.20 M -$10.78 M
EBITDA Ratio -30.85 -34.65 -196.06 -23.78 -561.1 -60.45 -39.92 -191.06 -34.1
Operating Income Ratio -31.17 -40.15 -199.06 -24.99 -566.62 -61.21 -37.68 -234.49 -64.11
Total Other Income/Expenses Net $101.00 K $2.63 M $91.00 K $110.00 K -$520.00 K $152.00 K -$2.24 M $2.35 M $6.32 M
Income Before Tax -$18.63 M -$20.25 M -$19.82 M -$22.38 M -$28.85 M -$31.86 M -$29.52 M -$18.76 M -$13.94 M
Income Before Tax Ratio -31 -35.53 -198.15 -24.87 -577.02 -60.92 -40.77 -208.43 -44.12
Income Tax Expense $0.00 $0.00 -$93.00 K $852.00 K $458.00 K $152.00 K -$1.85 M $1.28 M $2.99 M
Net Income -$18.63 M -$20.25 M -$19.72 M -$23.23 M -$29.31 M -$32.02 M -$29.52 M -$18.72 M -$13.94 M
Net Income Ratio -31 -35.53 -197.22 -25.81 -586.18 -61.21 -40.77 -208.02 -44.12
EPS -8.88 -43.68 -97.59 -170.04 -327.62 -521.95 -1186.7 -689.86 -526.85
EPS Diluted -8.88 -43.68 -97.59 -169.11 -327.62 -521.95 -1186.7 -689.86 -526.85
Weighted Average Shares Out $2.10 M $463.65 K $202.08 K $136.63 K $89.46 K $61.34 K $24.87 K $27.14 K $26.47 K
Weighted Average Shares Out Diluted $2.10 M $463.65 K $202.08 K $137.38 K $89.46 K $61.34 K $24.87 K $27.14 K $26.47 K
Link